title: Response to Comment on Ferrannini et al. Diabetes Care 2016;39:1108-1114. Comment on Mudaliar et al. Diabetes Care 2016;39:1115-1122.
authors.affiliation: CNR Institute of Clinical Physiology, Pisa, Italy ferranni@ifc.cnr.it.
authors.forename: Ele
authors.initials: E
authors.lastname: Ferrannini
authors.affiliation: Cardiometabolic Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Mark
authors.affiliation: Cardiometabolic Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.
authors.forename: Eric
authors.initials: E
authors.lastname: Mayoux
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006801:Humans